Jeffery will retire from Katz Group
Katz Group Canada/Rexall chief development officer Warren Jeffery will retire at the end of this month.
Latest
CVS, P&G develop ‘Guy Aisle’
Recognizing burgeoning demand for men’s grooming products, Procter & Gamble Co. (P&G) and a CVS/pharmacy unit here have created a prototype “Guy Aisle.
Rite Aid brings flu shots to N.Y.C. commuters
A Rite Aid Corp. flu shot event in Grand Central Terminal earlier this month helped inoculate hundreds of city residents against illness and raised money for charity.
Rosato named chief executive at AMCP
The Academy of Managed Care Pharmacy (AMCP) has named former National Association of Chain Drug Stores executive Edith Rosato chief executive officer. She succeeds Judith Cahill, who earlier this year announced that she would be retiring after 16 years as top executive at AMCP.
There is simply no one to replace DeMino
The people who founded, built and served the chain drug industry in this country during its halcyon days are rapidly disappearing from the scene. During the summer death claimed Charlie Bowlus, the founder and driving force behind ECRM.
Chain drug retailers think outside the box
Many drug chains can take justifiable pride in their efforts to rethink the shopping experience. Walgreen Co., Rite Aid Corp.
NACDS gives take on proposed Medicaid reimbursement caps
The National Association of Chain Drug Stores has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding its draft federal upper limit (FUL) list.
Report: In some categories, independents hold edge
Though the front end has traditionally been the province of chain drug stores, independent pharmacies are driving sales at a faster rate in six health-related categories, according to a new report from Hamacher Resource Group Inc.
Watson to market lower-dose testosterone patch
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.
Authorized generic pact signed by Prasco, Eli Lilly
Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.
Senate nixes provision for ‘personal importation’ of Rx
The Senate has voted down a measure that would have enabled personal importation of prescription drugs into the United States.
Bayer category manager joins Emerson Group
The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.
NCPA questions CMS calculations for FULs
The Centers for Medicare & Medicaid Services (CMS) is relying on flawed average manufacturer price (AMP) data to calculate new caps on Medicaid pharmacy reimbursement — known as federal upper limits (FULs) — for multiple-source generic prescription drugs, according to the National Community Pharmac
Abbott to split into two companies
Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
It’s official: Matrix renamed Mylan Laboratories
Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd. The name change is effective immediately, the company said.
Senior management changes at Bristol-Myers Squibb
Bristol-Myers Squibb Co. has announced some executive moves within its senior management team. The company said Wednesday that Giovanni Caforio has been promoted to president of U.S. Pharmaceuticals. He previously was senior vice president of oncology and immunology global commercialization.